ICD-10-CM Billable Code

T83.724

Exposure of implanted ureteral bulking agent into ureter

Clinical Classification Guidelines

Medical Intelligence & Overview

The exposure of an implanted ureteral bulking agent (ICD-10 Code T83.724) occurs when a material used to treat ureteral conditions becomes exposed within the ureter. This complication can happen after procedures aimed at treating urinary issues, particularly those involving the use of bulking agents to support or enhance ureteral function. Recognizing and understanding this condition is essential for proper management and to prevent further complications. This explanation provides a clear overview of what this diagnosis entails, its causes, symptoms, methods of diagnosis, and possible treatments.

Causes & Symptoms

Clinical Causes: Improper placement of the bulking agent during the initial procedure Insufficient tissue support leading to displacement or extrusion of the agent Infection or inflammation promoting tissue breakdown around the implanted material Mechanical stress or trauma to the ureter resulting in exposure of the device Material degradation over time causing exposure or erosion into surrounding tissues

Key Symptoms: Pain or discomfort in the pelvic or flank area Hematuria, or blood in the urine Urinary urgency or frequency Signs of infection such as fever or chills Possible urinary leakage or changes in urine flow

Diagnostic & Treatment

Diagnosis Path: Diagnosis of ureteral bulking agent exposure typically involves a combination of imaging studies and clinical evaluation:

Treatment Protocols: Managing exposure of an implanted ureteral bulking agent depends on severity and symptoms. Treatments may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T83.724 a billable ICD-10 code?
Yes, T83.724 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T83.724?
Clinical documentation must specify the nature of Exposure of implanted ureteral bulking agent into ureter and any associated comorbidities for accurate reporting.

Cite this Clinical Reference